Roland LogéRoland Logé is an associate professor at EPFL, with a primary affiliation to the Materials Institute, and a secondary affiliation to the Microengineering Institute.
After graduating in 1994 at UCL (Belgium) in Materials Engineering, he earned a Master of Science in Mechanics in 1995, at UCSB Santa Barbara (USA). He received his PhD at Mines Paristech-CEMEF (France) in 1999, where he specialized in metal forming and associated microstructure evolutions. After a postdoc at Cornell University (USA) between 1999 and 2001, he entered CNRS in France.
In 2008, he was awarded the ALCAN prize from the French Academy of Sciences, together with Yvan Chastel.
In 2009 he became head of the Metallurgy-Structure-Rheology research group at CEMEF.
In 2011, he launched a “Groupement de Recherche” (GDR), funded by CNRS, networking most of the researchers in France involved in recrystallization and grain growth.
In 2013, he became Research Director at CNRS.
In March 2014 he joined EPFL as the head of the Laboratory of Thermomechanical Metallurgy.
Christophe MoserChristophe Moser is Associate Professor of Optics and the Section Director in the Microengineering department at EPFL. He obtained his PhD at the California Institute of Technology in optical information processing in 2000. He co-founded and was the CEO of Ondax Inc (acquired by Coherent Inc.), Monrovia California for 10 years before joining EPFL in 2010. His current interests are ultra-compact endoscopic optical imaging through multimode fibers, multimode fiber lasers, retinal imaging and additive manufacturing via volumetric 3D printing with light. He is the co-founder of Composyt light lab in the field of head worn displays in 2014 (acquired by Intel Corp), Earlysight SA and Readily3D. He is the author and co-author of 75 peer reviewed publications and 45 patents.
Florian Maria WurmFlorian Wurm received his academic training as a Biologist and Molecular Geneticist at the University of Giessen. He joined the Hoechst AG (Behringwerke) in Marburg as head of a laboratory in Virology. Working with immortalized mammalian cells for the establishment of production processes for alpha-interferons provided the first opportunity to combine basic research with medical application. In 1984 he joined Harvard Medical School in Boston as a Research Fellow in Molecular Biology. 1986 he took an offer from Genentech Inc. in San Francisco to work in Process Sciences on the development of large scale manufacturing processes for recombinant proteins. There he has held a number of leading positions and has acquired intimate knowledge in the generation of protein pharmaceuticals in mammalian cells in bioreactors (a number of which are now marketed products). In 1995 he joined the EPFL as a Professor for Biotechnology. Wurm has published more than 250 scientific papers and holds more than 20 patents/patent-applications. His H-index stands at 60 in 2021. He was Chairman (2005-2009) and is member of the Executive Board of the European Society of Animal Cell Technology (ESACT). He serves as a consultant to the pharmaceutical Biotech Industry, mainly in the fields of animal cell technology for recombinant protein production and in regulatory affairs. He works as a scientific reviewer and editior/asscciate editor for a number of international journals in the Biotech field. F.M. Wurm teaches classes to pre- and postgraduate students in the fields of Molecular and Cellular Biotechnology.
He was founder and Chief Scientific Officer of ExcellGene SA, a 2001 established company in Monthey, Switzerland. He took the position of President and CEO of ExcellGene in 2015. He retired from the CEO position in 2017 and continues to be President and Chief Scientific Officer of ExcellGene.
In 2008 Dr. Wurm was appointed Visiting Professor for Biotechnology at Jinan University in Guangzhou, China. He retired from his position at the EPFL in 2015. His laboratory is closed. With his team at ExcellGene and in collaboration with Dr. Paco Pino, Director of R&D, he continues to explore manufacturing sciences with animal cells in bioreactors.
Ralf SeifertRalf W. Seifert is Professor of Technology & Operations Management (TOM) at the College of Management of Technology (CDM) at Ecole Polytechnique Fédérale de Lausanne (EPFL) since 2003. His primary research and teaching interests relate to operations management, supply chain strategy and technology network management. He is also active in industry analysis, international project work and new venture formation.
Based on his work with companies, Professor Seifert has co-authored more than 30 case studies covering different industries. These efforts have been recognized by multiple international case awards granted by EFMD in 2018, 2012, 2009 and 2003, ECCH in 2011 and 2006, as well as POMS in 2004. He continues to actively research issues of supply chain strategy, supply chain finance and technology management and has more than 70 articles and international conference presentations to his credit. In addition, he co-authored two books: one focused on strategic supply chain management and another one concerning start-up challenges of technology ventures.
In parallel to his appointment at EPFL, he continues to serve a position at IMD, were he has been appointed Professor of Operations Management in 2000. Prior to joining IMD, Professor Seifert studied and worked in Germany, Japan and the US. He earned PhD and MS degrees in Management Science at Stanford University, a Diplom Ingenieur degree in Mechanical Engineering at the Karlsruhe Institute of Technology (KIT) and a Master's degree in Integrated Manufacturing Systems Engineering from North Carolina State University. While in the US, he consulted for Hewlett-Packard and served as Teaching and Research Assistant at Stanford University. In Germany he worked for Booz & Company, McKinsey & Company and Freudenberg & Co. In addition, he spent one year as a Visiting Scholar in Operations Research at Waseda University in Tokyo.
